Ledger. Australian venture funding, tracked

Startup · $1m raised

Argenica Therapeutics

Developing ARG-007 to reduce disability in acute ischaemic stroke patients

What Argenica Therapeutics bought

Companies Argenica Therapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company KindAnnounced Price Sources
Argenica Therapeutics is not recorded as having acquired anything.

Something wrong? Tell us